Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Mogamulizumab with Open-Label Extension Study in a Minimum Number of Patients with Human T-cell Leukemia Virus Type-1-associated Myelopathy.

Tomoo Sato,Masahiro Nagai,Osamu Watanabe,Tatsuro Misu,Norihiro Takenouchi,Ryuichi Ohkubo,Satoshi Ishihara,Yoshio Tsuboi,Masahisa Katsuno,Masanori Nakagawa,Takuya Matsushita,Yasuhiro Aso,Eiji Matsuura,Takashi Tokashiki,Akihiro Mukaino,Hiroaki Adachi,Kaoru Nakanishi, Yusuke Yamaguchi, Saaya Yamaguchi,Yoshihisa Yamano

JOURNAL OF NEUROLOGY（2024）

引用 3|浏览26

关键词

KW-0761,Mogamulizumab,Human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis,Osame motor disability score,Neopterin,CXCL10

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要